RBP4 and gestational diabetes: Here, women with gestational diabetes mellitus showed significantly higher levels of serum RBP4, serum CysC, and nesfatin-1 versus healthy pregnant women (P < 0.05), indicating a possible association of abnormal serum RBP4, serum CysC, and nesfatin-1 levels with disease progression.